Abstract: The field of nanotechnology has been perplexing various areas within the law from day one. Yet, while legal challenges stemming from new technological developments are quite common, nanotechnology raises a unique kind of quandary. Namely, that it is not simply one technology or even one area of technology, but rather a whole different way of doing things. This, as one may expect, makes nanotechnology inadequate for categorization using the rather neat classifications that exist within the law. In other words: nanotechnology simply does not fit within any one legal “box.” In this talk I will further explain this fundamental challenge that nanotechnology poses to the law and discuss the many legal areas implicated by developments in nanotechnology.

Bio: Prof. Yaniv Heled researches and writes on legal and ethical aspects of biomedical technologies, such as biologics and biosimilars, stem cells, cloning and DNA sequencing and testing. He teaches Patent Law, Intellectual Property Survey and a seminar course on Law & Emerging Technologies, which examines the interaction of law and various cutting-edge technologies and how new technologies shape legal practice. Prof. Heled earned a J.S.D. from Columbia University School of Law. His doctoral dissertation focused on the regulation of novel biomedical technologies. In addition, Heled holds an LL.M. from Columbia, where he was a Harlan Fiske Stone Scholar, and an LL.B. and undergraduate Diploma in Biology, magna cum laude, from Tel Aviv University. Prior to Georgia State Law, Heled practiced intellectual property law with Goodwin Procter LLP in New York.